Hennion & Walsh Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,942
| Closed | -$1.09M | – | 915 |
|
|
2024
Q3 | $1.09M | Sell |
14,942
-1,569
| -10% | -$115K | 0.05% | 432 |
|
|
2024
Q2 | $1.13M | Sell |
16,511
-140
| -0.8% | -$9.59K | 0.06% | 395 |
|
|
2024
Q1 | $1.15M | Buy |
16,651
+2,090
| +14% | +$145K | 0.06% | 389 |
|
|
2023
Q4 | $1.04M | Sell |
14,561
-203
| -1% | -$14.5K | 0.06% | 395 |
|
|
2023
Q3 | $769K | Buy |
14,764
+1,066
| +8% | +$55.5K | 0.05% | 418 |
|
|
2023
Q2 | $867K | Buy |
13,698
+270
| +2% | +$17.1K | 0.05% | 399 |
|
|
2023
Q1 | $727K | Buy |
13,428
+2,280
| +20% | +$123K | 0.04% | 428 |
|
|
2022
Q4 | $590K | Buy |
+11,148
| New | +$590K | 0.04% | 463 |
|